Advertisement

Topics

Latest "Global ELISA Analyzers Market Data Survey Report 2025" News Stories

01:26 EDT 19th September 2018 | BioPortfolio

Here are the most relevant search results for "Global ELISA Analyzers Market Data Survey Report 2025" found in our extensive news archives from over 250 global news sources.

More Information about Global ELISA Analyzers Market Data Survey Report 2025 on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Global ELISA Analyzers Market Data Survey Report 2025 for you to read. Along with our medical data and news we also list Global ELISA Analyzers Market Data Survey Report 2025 Clinical Trials, which are updated daily. BioPortfolio also has a large database of Global ELISA Analyzers Market Data Survey Report 2025 Companies for you to search.

Showing "Global ELISA Analyzers Market Data Survey Report 2025" News Articles 1–25 of 51,000+

Wednesday 19th September 2018

RaQualia Pharma Inc 4579 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryRaQualia Pharma Inc RaQualia is a provider of discovery and development of pharmaceutical compounds. The company's products comprise anidulafungin, ziprasidone, dalbavancin, 5ht4 partial agonist, acid pump antagonist, 5HT2B antagonist, motilin receptor agonist, EP4 antagonist, cyclooxygenase2 inhibitor and 5HT4 partial agonist. Its products are used in treatment of gastroparesis, chronic co...


Profectus BioSciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09052018] Prices from USD $250

SummaryProfectus BioSciences Inc Profectus is a clinicalstage vaccine development company that designs and develops preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy. The company's products include genevax therapeutic vaccines, vesiculovax prophylactic vaccines and additional prophylactic vaccines. It uses PBS Vax technology platform for th...

Tuesday 18th September 2018

Italy Electrophysiology Devices Market Outlook to 2025 [Report Updated: 09042018] Prices from USD $4995

Italy Electrophysiology Devices Market Outlook to 2025SummaryGlobalData's new report, Italy Electrophysiology Devices Market Outlook to 2025, provides key market data on the Italy Electrophysiology Devices market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Cat...


Ionis Pharmaceuticals Inc IONS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 25042018] Prices from USD $250

SummaryIonis Pharmaceuticals Inc Ionis formerly ISIS Pharmaceuticals, Inc. is clinical stage biopharmaceutical company. It focuses on the discovery and development of RNAtargeted drugs. The company develops first inclass medicines for the treatment of cardiovascular and metabolic disorders, cancer and rare diseases. Ionis develops its products based on its proprietary antisense technology. Its lea...

JEFF Street will argue $VKTX is a possible M&A candidate&this may marginalize takeout potential - or at least scarcity value - expect this VKTX data will be a late- breaker at AASLD (where we are hosting a KOL investor event in San Francisco nov 9-13

JEFF Street will argue $VKTX is a possible M&A candidate&this may marginalize takeout potential - or at least scarcity value - expect this VKTX data will be a late- breaker at AASLD (where we are hosting a KOL investor event in San Francisco nov 9-13

argenx raises approximately $300.6 million in gross proceeds in a U.S. public offering

Regulated information - Inside information  September 18, 2018, 8:45 PM ET - September 19, 2018, 2:45 AM CEST Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, announced today the pr...

including a Phase 2 hip fracture recovery study with positive efficacy data. Data from a Phase 2, placebo- controlled ASTRID study of fellow SARM enobosarm in 4Q18 could be to $VKTX VK5211 in stress urinary incontinence (SUI), what $MDGL MGL-3196 was to V

including a Phase 2 hip fracture recovery study with positive efficacy data. Data from a Phase 2, placebo- controlled ASTRID study of fellow SARM enobosarm in 4Q18 could be to $VKTX VK5211 in stress urinary incontinence (SUI), what $MDGL MGL-3196 was to VK2809 in NASH.

Compromiso con el medio ambiente: NSK da pasos adicionales para mejorar su impronta global

ANN ARBOR, Michigan, 18 de septiembre de 2018 /PRNewswire/ -- Los fabricantes deben tener mucho cuidado en sus procesos y procedimientos de fabricación para garantizar Read more...

tranfection kits, fluorescent probes, nitric acid, cell counting, apoptosis, biotechnology

Manufacturer of, nitric oxide, neurochemicals, ligands, immunology, ELISA kits, caspases

Azzur Labs Celebrates 2nd Year As A Best Place To Work In Pennsylvania

For the second consecutive year, Azzur Labs has been named one of the Best Places to Work in PA. The awards program, created in 2000, is one of the first statewide programs of its kind in the country. LEHIGH VALLEY, Pa. (PRWEB) September 18, 2018 For the second consecutive year, Azzur Labs has been named one of the Best Places to Work in PA. The awards program, created in 2000, is one of the firs...

GSK facility design sees BPE shortlisted for global award

Process engineering firm BPE has been shortlisted for a global award after working with GSK to develop an approach that delivers a significant step change in the safe and efficient design of new facilities.The company, which specialises in chemical and biochemical engineering design, has been named as a finalist in the Industry Project category at the IChemE global awards. It joins the likes of Ex...

First laboratory-grown human-skin test service, to use artifical intelligence, to provide clinical trial standard verification for cosmetic, personal hygiene and skin care products

Labskin (Innovenn Ltd.), a wholly owned subsidiary of Integumen plc., (AIM:SKIN) today announces that it has entered into a partnership with RinoLab (www.rinolab.com) to provide Labskin clients with access to an AI machine learning platform which accelerates development of cosmetics, skincare, woundcare, personal hygiene and pharmaceutical topical drug delivery products. The service is expected to...

57% of Americans OK with Genetically Engineering Animals for Organ Transplants

A recent survey by the Pew Research Center found that 57 percent of Americans surveyed thought it was appropriate to use genetically engineered animals to grow organs for human transplants.

Analysis finds HPV vaccine safe

(Wiley) Infection with human papillomavirus (HPV) can cause certain cancers in women and men, but HPV vaccines are highly effective in preventing infection with oncogenic HPV types. A new British Journal of Clinical Pharmacology review of post-licensure data did not identify any new or unexpected safety concerns of the bivalent HPV vaccine.

Bacterial community structure in a sympagic habitat expanding with global warming: brackish ice brine at 85–90 °N

ASLAN, Sosei Pipeline Assets Hit By Development Delays

Two Asia-based companies disclose delays to important clinical pipeline assets, one in oncology driven by apparent ethnic differences in response...   

Global Heat Pumps Market to 2023 with Profiles of Major Players - Enertech Group, Bosch, ...

DUBLIN, Sept. 18, 2018 /PRNewswire/ -- The "Heat Pumps Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering. The heat Read more...

Opioid Bills Could Enhance US FDA Approval, Withdrawal Authority

House opioid package includes ability to deny or withdraw products because of abuse potential, but new Senate package does not...    

HealthEquity to Present at Investor Conference

DRAPER, Utah, Sept. 18, 2018 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY), the nation’s largest independent health savings account (HSA) custodian, today announced that it plans to participate at the 2018 Cantor Global Healthcare Conference in New York City. 2018 … Continue reading → Cet article HealthEquity to Present at Investor Conference est apparu en premier sur Bio...

Global Musculoskeletal Partnering 2012-2018: Updated Deal Trends, Players and Financials – Access to Headline, Upfront, Milestone and Royalty Data – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Musculoskeletal Partnering 2012-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. The Global Musculoskeletal Partnering 2012-2018: Deal trends, players and financials report provides an understanding and access to the Musculoskeletal partnering deals and … Continue reading &#...

Global Respiratory Partnering 2012-2018: Latest Deal Trends, Players and Financials – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Respiratory Partnering 2012-2018: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. The Global Respiratory Partnering 2012-2018: Deal trends, players and financials report provides an understanding and access to the Respiratory partnering deals and … Continue reading → Cet ar...

The Global $43.42bn Market for Anticoagulants (2018-2025): Analysis by Drug Class, Route of Administration and Application – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Anticoagulants Market by Drug Class, Route of Administration, and Application – Global Opportunity Analysis and Industry Forecast, 2018-2025” report has been added to ResearchAndMarkets.com’s offering. According to the report, the market was valued at $24,265 million in 2017, … Continue reading → Cet article The Global $43...

Tildrakizumab Set For Europe Debut - Can It Make A Dent?

Almirall's Ilumetri, licensed from Sun Pharma, has been cleared by the European Commission, upping the competition quotient in the psoriasis...   

Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP

Calyxt, Inc. (NASDAQ: CLXT) and Cellectis S.A. (NASDAQ: CLLS – EURONEXT GROWTH: ALCLS) announced today the appointment of James A. Blome, former President and CEO of Bayer CropScience LP (North America), as Chief Executive Officer of Calyxt, effective October 1, 2018. Jim Blome will work closely with Calyxt’s Board of Directors to foster the developmen...

#jobs #lifescience Life Science Technical Spectroscopy Specialist

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Life Science Technical Spectroscopy Specialist .MA-Boston, A global leader in high end imaging and detection platforms is seeking an experienced Field Service Engineer based in the Boston area. … Continue reading → Cet article #jobs #lifescience Life Science Techni...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks